abstract the present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. in particular, the method relates to a cancer treatment method which includes administering n- {3-chloro-4 - [(3-fluorobenzyl) oxy] phenyl} -6- [5 - ({[2- (methanesulphonyl) ethyl] amino } methyl) -2-furyl] -4-quinazolinamine, or a pharmaceutically acceptable hydrate and / or salt thereof, and n - {(1s) -2-amino-1 - [(3,4-difluorophenyl) methyl] ethyl} -5-chloro-4- (4-chloro-1-methyl-1h-pyrazol-5-yl) -2-furancarboxamide, or a pharmaceutically acceptable salt thereof, for a human in need thereof. _____________________________________________________________ patent summary: "combination". The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. in particular, the method relates to a cancer treatment method which includes administration of n- {3-chloro-4 - [(3-fluorobenzyl) oxy] phenyl} -6- [5 - ({[2- (methanesulfonyl ) ethyl] amino} methyl) -2-furyl] -4-quinazolinamine or a hydrate and / or a pharmaceutically acceptable salt thereof and n - {(1s) -2-amino-1 - [(3,4-difluorophenyl) methyl] ethyl} -5-chloro-4- (4-chloro-1-methyl-1h-pyrazol-5-yl) -2-furancarboxamide or a pharmaceutically acceptable salt thereof to a human in need thereof.abstract the present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. in particular, the method relates to a cancer treatment method that includes administering n-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine, or a pharmaceutically acceptable hydrate and/or salt thereof, and n-{(1s)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof. __________________
